Analysis of The Effect of Medication Therapy Management on Tuberculosis Patients
DOI:
https://doi.org/10.31941/benzena.v5i01.7986Keywords:
Medication Therapy Management; Tuberculosis; Treatment Adherence; Pharmacists; Therapy OutcomesAbstract
Background: Tuberculosis (TB) remains a global health problem with high incidence and mortality rates. The success of TB therapy is greatly influenced by patient adherence to long-term treatment. Medication Therapy Management (MTM) has been developed as a pharmaceutical care approach focused on optimizing medication use and improving patient outcomes.
Objective: This review aims to analyze the impact of Medication Therapy Management implementation on treatment outcomes in tuberculosis patients and identify opportunities and challenges for its implementation in healthcare practice.
Method: This study was conducted using a narrative review method by searching scientific articles from the PubMed, Google Scholar, Frontiers, and ScienceDirect databases. Articles published between 2016 and 2026 that discussed the implementation of MTM in tuberculosis patients were selected based on predetermined inclusion criteria. A total of 15 articles met the criteria and were analyzed descriptively.
Results: The review indicates that the implementation of MTM has contributed to improving treatment adherence, identifying and addressing drug-related problems, improving monitoring of drug side effects, and supporting the success of TB patient therapy. Pharmacist interventions through MTM components have also been reported to have the potential to improve patient quality of life and strengthen collaboration among healthcare professionals. However, MTM implementation still faces various obstacles, such as limited human resources, suboptimal documentation systems, and poor patient understanding of therapy.
Conclusion: Medication Therapy Management has demonstrated benefits in supporting successful tuberculosis treatment by improving adherence, safety, and effectiveness of therapy. Strengthening the role of pharmacists and providing support from the health system is needed to optimize MTM implementation in TB patients.
Keywords: Medication Therapy Management; Tuberculosis; Treatment Adherence; Pharmacists; Therapy Outcomes
Downloads
References
Alfaqeeh, M., Santoso, P., Alffenaar, J. W., & Pradipta, I. S. (2025). A Call to Action: Empowering Pharmacists in Drug-Resistant Tuberculosis Management. In Journal of Multidisciplinary Healthcare (Vol. 18, pp. 3531–3544). Dove Medical Press Ltd. https://doi.org/10.2147/JMDH.S517965
Alshammari, H. I., Alshibrain, S. M., Alhammadi, A. M., Algabren, K. T., & Alotaibi, F. M. (2025). Pharmacist-Led Interventions in Chronic Disease Management: A Systematic Review. In International Journal of Multidisciplinary Innovation and Research Methodology (IJMIRM) (Vol. 4, Number 2).
American Pharmacists Association and the National Association of Chain Drug Stores Foundation. (2008). Medication Therapy Management in Pharmacy Practice Core Elements of an MTM Service Model.
Asbi, A., Tong, S. F., & Sulaiman, N. (2023). Treatment outcomes of extended versus non-extended intensive phase in pulmonary tuberculosis smear positive patients with delayed sputum smear conversion: A retrospective cohort study at primary care clinics in Kota Kinabalu. Malaysian Family Physician, 18. https://doi.org/10.51866/oa.191
Guo, N., Marra, F., & Marra, C. A. (2009). Measuring health-related quality of life in tuberculosis: A systematic review. In Health and Quality of Life Outcomes (Vol. 7). https://doi.org/10.1186/1477-7525-7-14
Iskandar, D., Suryanegara, F. D. A., van Boven, J. F. M., & Postma, M. J. (2023). Clinical pharmacy services for tuberculosis management: a systematic review. In Frontiers in Pharmacology (Vol. 14). Frontiers Media SA. https://doi.org/10.3389/fphar.2023.1186905
Katende-Kyenda, L. N. (2025). Improving Tuberculosis Medication Adherence: A Millennial Disease in the Age of New Technologies: Application of the World Health Organization-Multidimensional Adherence Model: A Review. In Applied Sciences (Switzerland) (Vol. 15, Number 24). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/app152412910
Lv, L., Li, T., Xu, K., Shi, P., He, B., Kong, W., Wang, J., & Sun, J. (2018). Sputum bacteriology conversion and treatment outcome of patients with multidrug-resistant tuberculosis. Infection and Drug Resistance, 11, 147–154. https://doi.org/10.2147/IDR.S153499
Mardhiyyah, C. A., Nurfadila, F. S., Jamshed, S., Parwitha, I. A. A., Pitaloka, D. A. E., & Pradipta, I. S. (2026). Integrating community pharmacists in tuberculosis infection care: challenges and strategic approaches in Indonesia. BMC Health Services Research, 26(1). https://doi.org/10.1186/s12913-026-14254-2
Perwitasari, D. A. (2017). The Predicted Quality Adjusted Life Years (QALYS) Using St. George Respiratory Questionnaire (SGRQ) in Indonesian Tuberculosis Patients.
Pradipta, I. S., Houtsma, D., van Boven, J. F. M., Alffenaar, J. W. C., & Hak, E. (2020). Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies. In npj Primary Care Respiratory Medicine (Vol. 30, Number 1). Nature Research. https://doi.org/10.1038/s41533-020-0179-x
Rendrayani, F., Alfian, S. D., Wahyudin, W., & Puspitasari, I. M. (2023). Knowledge, attitude, and practice of medication therapy management: a national survey among pharmacists in Indonesia. Frontiers in Public Health, 11. https://doi.org/10.3389/fpubh.2023.1213520
Resende, N. H., SOUZA, J. A., MARTINS, Ú. C., REIS, A. M., MIRANDA, S. S., & CARVALHO, W. S. (2021). Gerenciamento da terapia medicamentosa em pacientes com tuberculose e HIV/aids: série de casos. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 12(4), 681. https://doi.org/10.30968/rbfhss.2021.124.0681
Sazali, M. F., Rahim, S. S. S. A., Mohammad, A. H., Kadir, F., Payus, A. O., Avoi, R., Jeffree, M. S., Omar, A., Ibrahim, M. Y., Atil, A., Tuah, N. M., Dapari, R., Lansing, M. G., Rahim, A. A. A., & Azhar, Z. I. (2023). Improving Tuberculosis Medication Adherence: The Potential of Integrating Digital Technology and Health Belief Model. In Tuberculosis and Respiratory Diseases (Vol. 86, Number 2, pp. 82–93). Korean National Tuberculosis Association. https://doi.org/10.4046/trd.2022.0148
Torres, N. M. C., Rodríguez, J. J. Q., Andrade, P. S. P., Arriaga, M. B., & Netto, E. M. (2019). Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis. PLoS ONE, 14(12). https://doi.org/10.1371/journal.pone.0226507
Umeh, A. U., Chima, U. E., Agbo, C. E., Chiekwe, O. S., Eze, A. E., Nwachuya, C. A., Mmuo, S. S., Nnedu, C. E., & Isah, A. (2025). Pharmacist-led medication therapy management: Impact on healthcare utilization and costs. American Journal of Pharmacotherapy and Pharmaceutical Sciences, 4, 4. https://doi.org/10.25259/ajpps_2025_004
Vita Lucya, & Nabila Triefitriani Arief. (2022). Factor_Affecting_Treatment_Compliance_in_TB_Patien. JURNAL KEPERAWATAN KOMPREHENSIF, Vol. 8 No. 4.
World Health Organization. (2025). tuberculosis Global report.
Yasin, N. M., Kurniawati, F., & Ridhayani, F. (2025). Bridging gaps in medication therapy management at community health centers: A mixed-methods study on patient perceptions and pharmacists’ preparedness. Exploratory Research in Clinical and Social Pharmacy, 17. https://doi.org/10.1016/j.rcsop.2024.100554
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Reza Nur Iman, Githa Fungie Galistiani, Indri Hapsari

This work is licensed under a Creative Commons Attribution 4.0 International License.
uthors who publish with BENZENA Pharmaceutical Scientific Journal agree to the following terms:- Authors retain copyright and grant the BENZENA Pharmaceutical Scientific Journal right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.



